Roth Capital Brokers Increase Earnings Estimates for Celsius

Key Points

• Roth Capital has raised its Q2 2026 earnings per share (EPS) estimate for Celsius Holdings Inc. from $0.31 to $0.34, maintaining a "Buy" rating with a price target of $52.00.
• The company's recent quarterly earnings showed an EPS of $0.18, falling short of analyst expectations, and revenue decreased by 7.4% compared to the same quarter last year.
• Multiple brokerages have increased their price targets for Celsius, with Needham & Company raising theirs to $55.00 and Wells Fargo adjusting to $45.00, reflecting a generally positive outlook among analysts.

Celsius Holdings Inc. (NASDAQ:CELH - Free Report) - Investment analysts at Roth Capital raised their Q2 2026 earnings per share (EPS) estimates for shares of Celsius in a research report issued to clients and investors on Thursday, July 31st. Roth Capital analyst S. Mcgowan now anticipates that the company will post earnings per share of $0.34 for the quarter, up from their previous estimate of $0.31. Roth Capital currently has a "Buy" rating and a $52.00 price target on the stock. The consensus estimate for Celsius' current full-year earnings is $0.89 per share. Roth Capital also issued estimates for Celsius' Q4 2026 earnings at $0.31 EPS and FY2027 earnings at $1.45 EPS.

A number of other brokerages have also weighed in on CELH. Citigroup started coverage on Celsius in a research note on Wednesday, July 23rd. They set a "buy" rating and a $55.00 price objective for the company. TD Cowen upgraded Celsius from a "hold" rating to a "buy" rating and lifted their target price for the stock from $37.00 to $55.00 in a research report on Monday, June 16th. Piper Sandler lifted their target price on Celsius from $44.00 to $45.00 and gave the stock an "overweight" rating in a research report on Wednesday, June 4th. Wells Fargo & Company lifted their target price on Celsius from $44.00 to $45.00 and gave the stock an "overweight" rating in a research report on Wednesday, June 4th. Finally, UBS Group lifted their target price on Celsius from $49.00 to $57.00 and gave the stock a "buy" rating in a research report on Thursday, July 17th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $47.83.

Celsius Trading Up 1.0%

NASDAQ CELH traded up $0.46 during mid-day trading on Friday, reaching $45.18. 4,254,029 shares of the company's stock traded hands, compared to its average volume of 8,117,840. Celsius has a 1-year low of $21.10 and a 1-year high of $48.47. The company has a fifty day simple moving average of $43.50 and a 200-day simple moving average of $35.50. The company has a market cap of $11.64 billion, a price-to-earnings ratio of 141.19, a P/E/G ratio of 1.58 and a beta of 1.40.

Celsius (NASDAQ:CELH - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.18 earnings per share for the quarter, missing analysts' consensus estimates of $0.20 by ($0.02). Celsius had a net margin of 8.40% and a return on equity of 42.12%. The business had revenue of $329.28 million for the quarter, compared to analyst estimates of $349.09 million. During the same quarter last year, the business earned $0.27 EPS. Celsius's revenue for the quarter was down 7.4% compared to the same quarter last year.

Insider Transactions at Celsius

In related news, major shareholder Deborah Desantis sold 100,000 shares of Celsius stock in a transaction on Monday, July 28th. The stock was sold at an average price of $47.00, for a total value of $4,700,000.00. Following the transaction, the insider directly owned 17,917,770 shares in the company, valued at $842,135,190. The trade was a 0.56% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, major shareholder William H. Milmoe sold 100,000 shares of Celsius stock in a transaction on Monday, July 28th. The stock was sold at an average price of $47.00, for a total value of $4,700,000.00. Following the completion of the transaction, the insider owned 17,917,770 shares in the company, valued at $842,135,190. The trade was a 0.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 762,974 shares of company stock valued at $35,158,418. Corporate insiders own 2.20% of the company's stock.

Hedge Funds Weigh In On Celsius

A number of hedge funds have recently modified their holdings of CELH. Alliancebernstein L.P. grew its holdings in shares of Celsius by 26.3% during the first quarter. Alliancebernstein L.P. now owns 18,045,178 shares of the company's stock valued at $642,769,000 after buying an additional 3,753,055 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of Celsius by 2.2% during the fourth quarter. Vanguard Group Inc. now owns 15,813,110 shares of the company's stock valued at $416,517,000 after buying an additional 345,837 shares in the last quarter. Alyeska Investment Group L.P. grew its holdings in shares of Celsius by 60.5% during the fourth quarter. Alyeska Investment Group L.P. now owns 6,877,918 shares of the company's stock valued at $181,164,000 after buying an additional 2,591,345 shares in the last quarter. FMR LLC grew its holdings in shares of Celsius by 64.2% during the fourth quarter. FMR LLC now owns 4,055,148 shares of the company's stock valued at $106,813,000 after buying an additional 1,585,839 shares in the last quarter. Finally, Champlain Investment Partners LLC purchased a new position in shares of Celsius during the fourth quarter valued at $85,068,000. 60.95% of the stock is currently owned by institutional investors and hedge funds.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.